Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 24, Issue 33, Pages 3695-3708
Publisher
Baishideng Publishing Group Inc.
Online
2018-09-06
DOI
10.3748/wjg.v24.i33.3695
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma
- (2018) Oriana Lo Re et al. HEPATOLOGY
- Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
- (2017) Minjong Lee et al. HEPATOLOGY
- Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
- (2017) Wenxia Shi et al. MEDICINE
- Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
- (2017) Conor A. Bradley et al. Nature Reviews Clinical Oncology
- Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling
- (2017) Chao-Yue Sun et al. Oncotarget
- Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma
- (2017) Andrew X. Zhu et al. JAMA Oncology
- Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment
- (2017) Benjamin Owusu et al. Cancers
- The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
- (2017) Chi-Tan Hu et al. Cancers
- A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
- (2016) W. M. Tai et al. ANNALS OF ONCOLOGY
- Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway
- (2016) Bin Jin et al. BMC CANCER
- Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations
- (2016) Christoph A. Thaiss et al. CELL
- Madecassoside suppresses proliferation and invasiveness of HGF-induced human hepatocellular carcinoma cells via PKC-cMET-ERK1/2-COX-2-PGE 2 pathway
- (2016) Zexin Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro
- (2016) Zhen Qu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets
- (2016) N A Wijetunga et al. ONCOGENE
- Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
- (2016) Ahmed Kaseb et al. OncoTargets and Therapy
- MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer
- (2016) Yongbing Chen et al. Oncotarget
- MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression
- (2016) Ming-Hua Hu et al. Oncotarget
- Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing
- (2016) Davide Degli Esposti et al. Oncotarget
- Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling
- (2016) Eunice Yuen Ting Lau et al. Cell Reports
- c-Met identifies a population of matrix metalloproteinase 9-producing monocytes in peritumoural stroma of hepatocellular carcinoma
- (2015) Lan Zhao et al. JOURNAL OF PATHOLOGY
- Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity
- (2015) J.-C. Jo et al. MOLECULAR CANCER THERAPEUTICS
- The Landscape of long noncoding RNA classification
- (2015) Georges St. Laurent et al. TRENDS IN GENETICS
- MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma
- (2015) Wei Ding et al. TUMOR BIOLOGY
- EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
- (2015) John E. Campbell et al. ACS Medicinal Chemistry Letters
- Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction
- (2015) Yoon Mee Yang et al. Oncotarget
- MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A
- (2015) Katsuya Ohta et al. Oncotarget
- Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells
- (2015) Javier A. García-Vilas et al. Scientific Reports
- miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met
- (2014) Peyda Korhan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The functional role of long non-coding RNAs and epigenetics
- (2014) Jinneng Cao BIOLOGICAL PROCEDURES ONLINE
- MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET
- (2014) Jian-Ya Zhou et al. CANCER LETTERS
- An Inducible Hepatocellular Carcinoma Model for Preclinical Evaluation of Antiangiogenic Therapy in Adult Mice
- (2014) A. Runge et al. CANCER RESEARCH
- Cabozantinib Suppresses Tumor Growth and Metastasis in Hepatocellular Carcinoma by a Dual Blockade of VEGFR2 and MET
- (2014) Q. Xiang et al. CLINICAL CANCER RESEARCH
- Role of MicroRNAs in Hepatocellular Carcinoma
- (2014) Zixiang Zhu et al. Hepatitis Monthly
- FAK Is required for c-Met/β-catenin-driven hepatocarcinogenesis
- (2014) Na Shang et al. HEPATOLOGY
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma
- (2014) Shu-Bin Gao et al. JOURNAL OF HEPATOLOGY
- Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues
- (2014) Makiko Kawaguchi et al. Cancers
- The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models
- (2014) Friedhelm Bladt et al. Cancers
- The emerging role of MET/HGF inhibitors in oncology
- (2013) Giorgio V. Scagliotti et al. CANCER TREATMENT REVIEWS
- Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
- (2013) L. Goyal et al. CLINICAL CANCER RESEARCH
- Targeting MET: why, where and how?
- (2013) Elena Ghiso et al. CURRENT OPINION IN PHARMACOLOGY
- Met/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes
- (2013) Mizuho Nakayama et al. CYTOKINE
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
- (2013) Virginia Hernandez–Gea et al. GASTROENTEROLOGY
- MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway
- (2013) Xin Yang et al. HEPATOLOGY
- MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway
- (2013) Xin Yang et al. HEPATOLOGY
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
- (2012) P. R. Gavine et al. CANCER RESEARCH
- Targeted therapy of hepatocellular carcinoma: Present and future
- (2012) Stephen L Chan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis
- (2012) Giray Bozkaya et al. Molecular Cancer
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacokinetic drivers of toxicity for basic molecules: Strategy to lower pKa results in decreased tissue exposure and toxicity for a small molecule Met inhibitor
- (2012) Dolores Diaz et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met
- (2011) Zheng-sheng Wu et al. CANCER
- MicroRNA-148a Suppresses Tumor Cell Invasion and Metastasis by Downregulating ROCK1 in Gastric Cancer
- (2011) B. Zheng et al. CLINICAL CANCER RESEARCH
- VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2
- (2011) Apostolos C. Ziogas et al. INTERNATIONAL JOURNAL OF CANCER
- Functional analysis of microRNAs in human hepatocellular cancer stem cells
- (2011) Fanyin Meng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A hepatocyte growth factor receptor (Met)−insulin receptor hybrid governs hepatic glucose metabolism
- (2011) Arlee Fafalios et al. NATURE MEDICINE
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- Tumor-Associated Lymphangiogenesis Correlates with Prognosis after Resection of Human Hepatocellular Carcinoma
- (2009) Armin Thelen et al. ANNALS OF SURGICAL ONCOLOGY
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis
- (2008) Maresa Caunt et al. CANCER CELL
- Molecular cancer therapy: Can our expectation be MET?
- (2008) Cristina Migliore et al. EUROPEAN JOURNAL OF CANCER
- Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression
- (2008) Pankaj K. Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer
- (2008) Mohd W. Nasser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNAmiR-199a*Regulates theMETProto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2)
- (2008) Seonhoe Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Direct Interaction between SET8 and Proliferating Cell Nuclear Antigen Couples H4-K20 Methylation with DNA Replication
- (2008) Michael S. Y. Huen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now